Daily metformin use in the month before pregnancy is associated with more than 70% reduction in risk for hyperemesis ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

In the early 2000s a clinical trial showed that lifestyle modification was better than metformin at preventing Type 2 ...

Rapamycin may help prolong life as much as some dietary interventions, according to animal research. These findings, though, ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

“Metformin is a widely used, first-line medication for treating type 2 diabetes.It belongs to a class of drugs called biguanides,” says Hans J. Schmidt, M.D., chief of bariatric surgery and ...

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

In the early 2000s the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, showed that intensive lifestyle modification was ...

A new study published in the American Journal of Obstetrics and Gynaecology revealed that for women with polycystic ovary ...